Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease | Zendy

Fátima Rodríguez | Zendy; David J. Maron | Zendy; Joshua W. Knowles | Zendy; Salim S. Virani | Zendy; Shoutzu Lin | Zendy; Paul A. Heidenreich | Zendy

AI Assistant Blog Pricing

Open Access

Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease

Author(s) -

Fátima Rodríguez,

David J. Maron,

Joshua W. Knowles,

Salim S. Virani,

Shoutzu Lin,

Paul A. Heidenreich

Publication year - 2016

Publication title -

jama cardiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.108

H-Index - 63

eISSN - 2380-6591

pISSN - 2380-6583

DOI - 10.1001/jamacardio.2016.4052

Subject(s) - medicine , statin , veterans affairs , retrospective cohort study , medical prescription , atherosclerotic cardiovascular disease , physical therapy , disease , pharmacology

High-intensity statin therapy is recommended for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD). Nevertheless, statin therapy in general, and high-intensity statin therapy in particular, is underused in patients with established ASCVD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog